We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $137M
1-Year Est. Return 21.22%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+21.22%
3 Year Est. Return
+42.93%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$4M
Cap. Flow
-$16.3M
Cap. Flow %
-13.68%
Top 10 Hldgs %
50.5%
Holding
190
New
12
Increased
26
Reduced
47
Closed
15

Top Buys

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$2.18M
2
NTR icon
Nutrien
NTR
+$919K
3
APD icon
Air Products & Chemicals
APD
+$602K
4
NEM icon
Newmont
NEM
+$218K
5
CUBE icon
CubeSmart
CUBE
+$210K

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.21%
2 Technology 13.47%
3 Real Estate 10.46%
4 Industrials 6.21%
5 Materials 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$85.2B
$303K 0.25%
345
HD icon
52
Home Depot
HD
$320B
$278K 0.23%
803
-9
-1% -$2.79K
PAYX icon
53
Paychex
PAYX
$43.3B
$267K 0.22%
2,238
-1,188
-35% -$141K
COST icon
54
Costco
COST
$406B
$259K 0.22%
392
MRK icon
55
Merck
MRK
$371B
$237K 0.2%
2,175
DVY icon
56
iShares Select Dividend ETF
DVY
$23.9B
$219K 0.18%
1,871
+4
+0.2% +$440
CSCO icon
57
Cisco
CSCO
$431B
$190K 0.16%
3,770
+138
+4% +$7.05K
VOT icon
58
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.4B
$184K 0.15%
837
IGSB icon
59
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$183K 0.15%
3,577
-83
-2% -$4.17K
BAC icon
60
Bank of America
BAC
$438B
$173K 0.15%
5,145
+11
+0.2% +$320
LLY icon
61
Eli Lilly
LLY
$1.02T
$130K 0.11%
223
VIG icon
62
Vanguard Dividend Appreciation ETF
VIG
$113B
$126K 0.11%
741
+8
+1% +$1.29K
TSM icon
63
TSMC
TSM
$2.22T
$125K 0.1%
1,200
USMV icon
64
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
$115K 0.1%
1,475
ED icon
65
Consolidated Edison
ED
$39.7B
$101K 0.08%
1,114
WFC icon
66
Wells Fargo
WFC
$272B
$100K 0.08%
2,036
PECO icon
67
Phillips Edison & Co
PECO
$5.01B
$92.2K 0.08%
2,527
CMCSA icon
68
Comcast
CMCSA
$94B
$90.6K 0.08%
2,066
+5
+0.2% +$214
META icon
69
Meta Platforms (Facebook)
META
$1.57T
$86.7K 0.07%
245
-25
-9% -$8.14K
NFLX icon
70
Netflix
NFLX
$326B
$85.2K 0.07%
1,750
CVS icon
71
CVS Health
CVS
$124B
$73.2K 0.06%
927
-12
-1% -$854
DLTR icon
72
Dollar Tree
DLTR
$24.7B
$71K 0.06%
500
PFE icon
73
Pfizer
PFE
$162B
$70.5K 0.06%
2,448
+181
+8% +$5.47K
AMGN icon
74
Amgen
AMGN
$236B
$68.3K 0.06%
237
GD icon
75
General Dynamics
GD
$97.2B
$65.4K 0.05%
252

Similar funds

Syntax Research's Q4 2023 Portfolio in Review

As of Q4 2023, Syntax Research held 190 positions worth $119M, down 3.2% from $123M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Syntax Research withdrew a net $16.3M in Q4 2023, closing 15 positions and reducing 47 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $1.14M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 62% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Syntax Research opened a new position in Archer Daniels Midland worth $2.15M.

  • Syntax Research's largest Q4 2023 buy was Archer Daniels Midland: 29,832 shares worth $2.15M.
  • Syntax Research added most to Nutrien in Q4 2023, an estimated $919K increase.
  • Syntax Research's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $3.45M.
  • Syntax Research fully exited iShares MSCI Emerging Markets ETF in Q4 2023, selling an estimated $1.14M.
  • Syntax Research's ten largest holdings make up 50% of its $119M portfolio in Q4 2023.
  • Syntax Research opened 12 new positions and closed 15 in Q4 2023.
  • Syntax Research's portfolio value fell 3.2% quarter-over-quarter to $119M.

Based on Syntax Research's 13F filing for Q4 2023, filed 30 Jan 2024.